Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Explore the potential path for dollar tree (dltr) 2026. This guide breaks down earnings signals, margins, store strat...
Disney is navigating a leadership transition alongside a liquidity push, triggering a clear bull-bear debate for inve...
P3 Health is shaping the future of value-based care with its platform. This guide breaks down what to expect from hea...
Global demand for AI-enabled services meets market volatility. This guide breaks down Globant's strategy, risks, and ...
When a tech giant pulls back from its peak, it creates both risk and opportunity. This guide breaks down why Meta Pla...
Rocket Lab has surged more than 350% in a year, but investors remain split on the sustainability of the rally as back...
In 2026, investors face a classic showdown: a rapid-growth dermatology
As July 22 approaches, investors wonder if AMD stock could spark a move. This guide breaks down catalysts, risks, and...
Broadcom is moving deeper into AI infrastructure, signaling a shift that could influence chip design, data-center cos...
Rivian stock fell first half 2026 as a mix of delivery updates, new model momentum, and macro headwinds shaped invest...
Lucid Group delivered a stronger top line in Q4, but cash burn remains a key hurdle. Investors will parse the mix of ...